{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-098429","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2025-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.602499+00:00","generated_at":"2026-05-18T02:23:48.693645+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Aptevo shareholders approve reverse stock split and Yorkville equity issuance","bullets":["Elected directors Marvin L. White (443,945 for) and John E. Niederhuber (444,661 for) to board.","Approved reverse stock split at ratio 1:6 to 1:20, board to set timing and exact ratio.","Approved issuance of >19.99% of outstanding shares under SEPA with YA II PN, Ltd. (Yorkville).","Approved Third Amended and Restated 2018 Stock Incentive Plan and non-binding advisory say-on-pay.","Ratified Baker Tilly as independent auditor for fiscal 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-098429","json":"https://secwatch.observer/filing/0000950170-25-098429.json","markdown":"https://secwatch.observer/filing/0000950170-25-098429.md","text":"https://secwatch.observer/filing/0000950170-25-098429.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025098429/0000950170-25-098429-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025098429/apvo-20250724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T02:23:48.693645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}